A Phase I/II Trial of EMB-02, a Bi-specific Antibody against PD-1 and LAG3, in Patients with Advanced Solid Tumors

Project: Research

Project Details

StatusActive
Effective start/end date27/10/21 → 26/10/26

Keywords

  • phase 1 and 2 study
  • treatment tolerability
  • antibody cancer therapy
  • solid tumours
  • treatment efficacy